litlas
Log inCreate account

David A. Palma

Active 2008–2026

137
Papers
18,421
Citations
66
h-index
131
i10-index

Citations

Citations per year for David A. Palma1981: 1 citations1994: 3 citations2001: 1 citations2008: 4 citations2009: 17 citations2010: 23 citations2011: 33 citations2012: 35 citations2013: 49 citations2014: 92 citations2015: 80 citations2016: 70 citations2017: 79 citations2018: 85 citations2019: 520 citations2020: 932 citations2021: 681 citations2022: 585 citations2023: 386 citations2024: 719 citations2025: 253 citations2026: 7 citations1982–1993: no citations, so these years are not shown1995–2000: no citations, so these years are not shown2002–2007: no citations, so these years are not shown

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 1,206 citing papers, 21.9% of this breakdownChina: 427 citing papers, 7.7% of this breakdownCanada: 396 citing papers, 7.2% of this breakdownItaly: 364 citing papers, 6.6% of this breakdownUnited Kingdom: 357 citing papers, 6.5% of this breakdownNetherlands: 296 citing papers, 5.4% of this breakdownGermany: 294 citing papers, 5.3% of this breakdownFrance: 213 citing papers, 3.9% of this breakdownAustralia: 198 citing papers, 3.6% of this breakdownSwitzerland: 197 citing papers, 3.6% of this breakdownBelgium: 156 citing papers, 2.8% of this breakdownJapan: 133 citing papers, 2.4% of this breakdown
0%21.9%Other 23.1%

Institutions

Fields

  • Medicine83.7%
  • Physics and Astronomy7.5%
  • Biochemistry, Genetics and Molecular Biology4.7%
  • Engineering0.9%
  • Health Professions0.8%
  • Computer Science0.7%
  • Other1.7%

Topics

  • Lung Cancer Diagnosis and Treatment10.8%
  • Advanced Radiotherapy Techniques7%
  • Head and Neck Cancer Studies5.1%
  • Lung Cancer Treatments and Mutations4.9%
  • Radiomics and Machine Learning in Medical Imaging4.5%
  • Hepatocellular Carcinoma Treatment and Prognosis4%
  • Other63.7%

Coauthors

All papers

Open in search
  1. Stereotactic ablative radiotherapy versus standard of care palliative treatment in patients with oligometastatic cancers (SABR-COMET): a randomised, phase 2, open-label trial

    Authors: David A. Palma, Robert Olson, Stephen Harrow, Stewart Gaede, Alexander V. Louie, Cornelis J.A. Haasbeek, Liam Mulroy, Michael Lock, George Rodrigues, Brian Yaremko, Devin Schellenberg, Belal Ahmad, Gwendolyn H.M.J. Griffioen, Sashendra Senthi, Anand Swaminath, Neil Kopek, Mitchell Liu, Karen Moore, Suzanne Currie, Glenn Bauman, Andrew Warner, Suresh Senan - The Lancet 2019 cited by 1,859

  2. Local Consolidative Therapy Vs. Maintenance Therapy or Observation for Patients With Oligometastatic Non–Small-Cell Lung Cancer: Long-Term Results of a Multi-Institutional, Phase II, Randomized Study

    Authors: Daniel R. Gomez, Chad Tang, Jianjun Zhang, George R. Blumenschein, Mike Hernández, J. Jack Lee, Rong Ye, David A. Palma, Alexander V. Louie, D. Ross Camidge, Robert C. Doebele, Ferdinandos Skoulidis, Laurie E. Gaspar, James W. Welsh, Don L. Gibbons, José A. Karam, Brian D. Kavanagh, Anne S. Tsao, Boris Sepesi, Stephen G. Swisher, John V. Heymach - Journal of Clinical Oncology 2019 cited by 1,270

  3. Defining oligometastatic disease from a radiation oncology perspective: An ESTRO-ASTRO consensus document

    Authors: Yolande Lievens, Matthias Gückenberger, Daniel R. Gomez, Morten Høyer, Puneeth Iyengar, I. Kindts, Alejandra Romero, Daan Nevens, David A. Palma, Catherine Park, Umberto Ricardi, Marta Scorsetti, James B. Yu, Wendy A. Woodward - Radiotherapy and Oncology 2020 cited by 655

  4. Local consolidative therapy versus maintenance therapy or observation for patients with oligometastatic non-small-cell lung cancer without progression after first-line systemic therapy: a multicentre, randomised, controlled, phase 2 study

    Authors: Daniel R. Gomez, George R. Blumenschein, J Jack Lee, Mike Hernández, Rong Ye, D. Ross Camidge, Robert C. Doebele, Ferdinandos Skoulidis, Laurie E. Gaspar, Don L. Gibbons, José A. Karam, Brian D. Kavanagh, Chad Tang, Ritsuko Komaki, Alexander V. Louie, David A. Palma, Anne S. Tsao, Boris Sepesi, William N. William, Jianjun Zhang, Qiuling Shi, Xin Shelley Wang, Stephen G. Swisher, John V. Heymach - The Lancet Oncology 2016 cited by 1,086

  5. Radiotherapy versus transoral robotic surgery and neck dissection for oropharyngeal squamous cell carcinoma (ORATOR): an open-label, phase 2, randomised trial

    Authors: Anthony C. Nichols, Julie Theurer, Eitan Prisman, Nancy Read, Eric Berthelet, Eric Tran, Kevin Fung, John R. de Almeida, Andrew Bayley, David P. Goldstein, Michael Hier, Khalil Sultanem, Keith Richardson, Alex Mlynarek, Suren Krishnan, Hien Le, John Yoo, S. Danielle MacNeil, Eric Winquist, J. Alex Hammond, Varagur Venkatesan, Sara Kuruvilla, Andrew Warner, Sylvia Mitchell, Jeff Chen, Martin Corsten, Stephanie Johnson‐Obaseki, Libni Eapen, Michael Odell, Christina Parker, Bret Wehrli, Keith Kwan, David A. Palma - The Lancet Oncology 2019 cited by 462

  6. Predicting Radiation Pneumonitis After Chemoradiation Therapy for Lung Cancer: An International Individual Patient Data Meta-analysis

    Authors: David A. Palma, Suresh Senan, Kayoko Tsujino, R. Bryan Barriger, Ramesh Rengan, Marta Moreno, Jeffrey D. Bradley, Tae Hyun Kim, Sara Ramella, Lawrence B. Marks, Luigi De Petris, Larry Stitt, George Rodrigues - International Journal of Radiation Oncology*Biology*Physics 2013 cited by 674

  7. Stereotactic Radiation for the Comprehensive Treatment of Oligometastases (SABR-COMET): Extended Long-Term Outcomes

    Authors: Stephen Harrow, David A. Palma, Robert Olson, Stewart Gaede, Alexander V. Louie, Cornelis J.A. Haasbeek, Liam Mulroy, Michael Lock, George Rodrigues, Brian Yaremko, Devin Schellenberg, Belal Ahmad, Sashendra Senthi, Anand Swaminath, Neil Kopek, Mitchell Liu, Roel Schlijper, Glenn Bauman, Joanna Laba, Xiaotao Qu, Andrew Warner, Suresh Senan - International Journal of Radiation Oncology*Biology*Physics 2022 cited by 202

  8. Randomized Trial of Radiotherapy Versus Transoral Robotic Surgery for Oropharyngeal Squamous Cell Carcinoma: Long-Term Results of the ORATOR Trial

    Authors: Anthony C. Nichols, Julie Theurer, Eitan Prisman, Nancy Read, Eric Berthelet, Eric Tran, Kevin Fung, John R. de Almeida, Andrew Bayley, David P. Goldstein, Michael Hier, Khalil Sultanem, Keith Richardson, Alex Mlynarek, Suren Krishnan, Hien Le, John Yoo, S. Danielle MacNeil, Eric Winquist, J. Alex Hammond, Varagur Venkatesan, Sara Kuruvilla, Andrew Warner, Sylvia Mitchell, Jeff Chen, Martin Corsten, Stephanie Johnson-Obaseki, Michael Odell, Christina Parker, Bret Wehrli, Keith Kwan, David A. Palma - Journal of Clinical Oncology 2022 cited by 170

  9. Stereotactic ablative radiotherapy for the comprehensive treatment of 4–10 oligometastatic tumors (SABR-COMET-10): study protocol for a randomized phase III trial

    Authors: David A. Palma, Robert Olson, Stephen Harrow, Rohann Correa, Famke L. Schneiders, Cornelis J.A. Haasbeek, George Rodrigues, Michael Lock, Brian Yaremko, Glenn Bauman, Belal Ahmad, Devin Schellenberg, Mitchell Liu, Stewart Gaede, Joanna Laba, Liam Mulroy, Sashendra Senthi, Alexander V. Louie, Anand Swaminath, Anthony J. Chalmers, Andrew Warner, Ben J. Slotman, Tanja D. de Gruijl, Alison L. Allan, Suresh Senan - BMC Cancer 2019 cited by 268

  10. Assessment of Toxic Effects and Survival in Treatment Deescalation With Radiotherapy vs Transoral Surgery for HPV-Associated Oropharyngeal Squamous Cell Carcinoma

    Authors: David A. Palma, Eitan Prisman, Eric Berthelet, Eric Tran, Sarah Hamilton, Jonn Wu, Antoine Eskander, Kevin Higgins, Irene Karam, Ian Poon, Zain Husain, Danny Enepekides, Michael Hier, Khalil Sultanem, Keith Richardson, Alex Mlynarek, Stephanie Johnson‐Obaseki, Michael Odell, Andrew Bayley, Samuel Dowthwaite, James E. Jackson, Marcin Dzienis, John O’Neil, Shamir Chandarana, Robyn Banerjee, Robert D. Hart, Jeffson Chung, Todd Tenenholtz, Suren Krishnan, Hien Le, John Yoo, Adrian Mendez, Eric Winquist, Sara Kuruvilla, Paul Stewart, Andrew Warner, Sylvia Mitchell, Jeff Chen, Christina Parker, Bret Wehrli, Keith Kwan, Julie Theurer, Jinka Sathya, J. Alex Hammond, Nancy Read, Varagur Venkatesan, S. Danielle MacNeil, Kevin Fung, Anthony C. Nichols - JAMA Oncology 2022 cited by 102

  11. Practical Management of Oligometastatic Non–Small-Cell Lung Cancer

    Authors: Katie Jasper, Brendon M. Stiles, Fiona McDonald, David A. Palma - Journal of Clinical Oncology 2022 cited by 99

  12. The Dandelion Dilemma Revisited for Oligoprogression: Treat the Whole Lawn or Weed Selectively?

    Authors: Priyanka Patel, David A. Palma, Fiona McDonald, Alison Tree - Clinical Oncology 2019 cited by 118

  13. The genomic and evolutionary landscapes of anaplastic thyroid carcinoma

    Authors: Peter YF. Zeng, Stephenie D. Prokopec, Stephen Y. Lai, Nicole Pinto, Michelle Chan‐Seng‐Yue, Roderick Clifton‐Bligh, Michelle D. Williams, Christopher J. Howlett, Paul Plantinga, Matthew J. Cecchini, Alfred K. Lam, Iram Siddiqui, Jianxin Wang, Ren Sun, John D. Watson, Reju Korah, Tobias Carling, Nishant Agrawal, Nicole A. Cipriani, Douglas W. Ball, Barry D. Nelkin, Lisa M. Rooper, Justin A. Bishop, Cathie Garnis, Ken Berean, Norman G. Nicolson, Paul Weinberger, Ying C. Henderson, Christopher M. Lalansingh, Mao Tian, Takafumi N. Yamaguchi, Julie Livingstone, Adriana Salcedo, Krupal Patel, Frederick S. Vizeacoumar, Alessandro Datti, Xi Liu, Yuri E. Nikiforov, Robert C. Smallridge, John A. Copland, Laura A. Marlow, Martin Hyrcza, Leigh Delbridge, Stan B. Sidhu, Mark Sywak, Bruce Robinson, Kevin Fung, Farhad Ghasemi, Keith Kwan, S. Danielle MacNeil, Adrian Mendez, David A. Palma, Mohammed Imran Khan, Mushfiq Hassan Shaikh, Kara M. Ruicci, Bret Wehrli, Eric Winquist, John Yoo, Joe S. Mymryk, James W. Rocco, David A. Wheeler, Steve Scherer, Thomas J. Giordano, John W. Barrett, William C. Faquin, Anthony J. Gill, Gary L. Clayman, Paul C. Boutros, Anthony C. Nichols - Cell Reports 2024 cited by 73

  14. An Individual Patient Data Metaanalysis of Outcomes and Prognostic Factors After Treatment of Oligometastatic Non–Small-Cell Lung Cancer

    Authors: A. Ashworth, Suresh Senan, David A. Palma, Marc Riquet, Yong Chan Ahn, Umberto Ricardi, Maria Teresa Congedo, Daniel R. Gomez, Gavin Wright, Giulio Melloni, Michael T. Milano, Claudio V. Sole, Tommaso Martino De Pas, Dennis L. Carter, Andrew J. Warner, George Rodrigues - Clinical Lung Cancer 2014 cited by 438

  15. Treatment-Related Toxicity in Patients With Early-Stage Non-Small Cell Lung Cancer and Coexisting Interstitial Lung Disease: A Systematic Review

    Authors: Hanbo Chen, Suresh Senan, Esther J. Nossent, Gabriel Boldt, Andrew Warner, David A. Palma, Alexander V. Louie - International Journal of Radiation Oncology*Biology*Physics 2017 cited by 161

  16. Stereotactic ablative radiotherapy for comprehensive treatment of oligometastatic tumors (SABR-COMET): Study protocol for a randomized phase II trial

    Authors: David A. Palma, Cornelis J.A. Haasbeek, George Rodrigues, Max Dahele, Michael Lock, Brian Yaremko, Robert Olson, Mitchell Liu, Jason Panarotto, GwendolynHMJ Griffioen, Stewart Gaede, Ben J. Slotman, Suresh Senan - BMC Cancer 2012 cited by 309

  17. Immune-based classification of HPV-associated oropharyngeal cancer with implications for biomarker-driven treatment de-intensification

    Authors: Peter YF. Zeng, Matthew J. Cecchini, John W. Barrett, Matthew Shammas‐Toma, Loris De Cecco, Mara Serena Serafini, Stefano Cavalieri, Lisa Licitra, Frank Hoebers, Ruud H. Brakenhoff, C. René Leemans, Kathrin Scheckenbach, Tito Poli, Xiaowei Wang, Xinyi Liu, Francisco Laxague, Eitan Prisman, Catherine F. Poh, Pinaki Bose, Joseph C. Dort, Mushfiq Hassan Shaikh, Sarah E.B. Ryan, Alice Dawson, Mohammed Imran Khan, Christopher J. Howlett, William Stecho, Paul Plantinga, Sabrina Daniela da Silva, Michael Hier, Halema Khan, Danielle MacNeil, Adrian Mendez, John Yoo, Kevin Fung, Pencilla Lang, Eric Winquist, David A. Palma, Hedyeh Ziai, Antonio L. Amelio, Shawn Li, Paul C. Boutros, Joe S. Mymryk, Anthony C. Nichols - EBioMedicine 2022 cited by 38

  18. Radiographic changes after lung stereotactic ablative radiotherapy (SABR) – Can we distinguish recurrence from fibrosis? A systematic review of the literature

    Authors: Kitty Huang, Max Dahele, Suresh Senan, Matthias Gückenberger, George Rodrigues, Aaron D. Ward, Gabriel Boldt, David A. Palma - Radiotherapy and Oncology 2012 cited by 230

  19. Artificial Intelligence in Lung Cancer: Bridging the Gap Between Computational Power and Clinical Decision-Making

    Authors: Jaryd R. Christie, Pencilla Lang, Lauren M. Zelko, David A. Palma, Mohamed Abdelrazek, Sarah A. Mattonen - Canadian Association of Radiologists Journal 2020 cited by 48

  20. A Primer on Interstitial Lung Disease and Thoracic Radiation

    Authors: Christopher D. Goodman, Suzan F. M. Nijman, Suresh Senan, Esther J. Nossent, Christopher J. Ryerson, Inderdeep Dhaliwal, Xiaotao Qu, Joanna Laba, George Rodrigues, David A. Palma - Journal of Thoracic Oncology 2020 cited by 86

  21. Impact of Introducing Stereotactic Lung Radiotherapy for Elderly Patients With Stage I Non–Small-Cell Lung Cancer: A Population-Based Time-Trend Analysis

    Authors: David A. Palma, Otto Visser, Frank J. Lagerwaard, J. Belderbos, Ben J. Slotman, Suresh Senan - Journal of Clinical Oncology 2010 cited by 478

  22. ADT with SBRT versus SBRT alone for hormone-sensitive oligorecurrent prostate cancer (RADIOSA): a randomised, open-label, phase 2 clinical trial

    Authors: Giulia Marvaso, Giulia Corrao, Mattia Zaffaroni, Maria Giulia Vincini, Chiara Lorubbio, Sara Gandini, Cristiana Fodor, Sofia Netti, Dario Zerini, Stefano Luzzago, Francesco Mistretta, Konstantinos Venetis, Giulia Cursano, Tiziana Burla, Ketti Mazzocco, Federica Cattani, Giuseppe Petralia, Nicola Fusco, Gabriella Pravettoni, Gennaro Musi, Ottavio De Cobelli, Chad Tang, Piet Ost, David A. Palma, Roberto Orecchia, Barbara Alicja Jereczek‐Fossa - The Lancet Oncology 2025 cited by 77

  23. Stereotactic Ablative Radiation for Oligoprogressive Cancers: Results of the Randomized Phase 2 STOP Trial

    Authors: Devin Schellenberg, Zsolt Gabos, Adele Duimering, Brock Debenham, Alysa Fairchild, Fleur Huang, Lindsay Rowe, Diane Severin, Meredith Giuliani, Andrea Bezjak, Benjamin H. Lok, Srinivas Raman, Peter Chung, Yizhou Zhao, Clement Ho, Michael Lock, Alexander V. Louie, Shilo Lefresne, Hannah Carolan, Mitchell Liu, Vivian Yau, Allison Ye, Robert Olson, Benjamin Mou, Islam Mohamed, David Petrik, Maryam Dosani, Howard Pai, Boris Valev, Stewart Gaede, Andrew Warner, David A. Palma - International Journal of Radiation Oncology*Biology*Physics 2024 cited by 36

  24. Oligometastases: Emerging Evidence

    Authors: Wei Liu, Houda Bahig, David A. Palma - Journal of Clinical Oncology 2022 cited by 45